Why BofA Is Turning Bullish On Prelude Therapeutics
Prelude Therapeutics Inc’s (NASDAQ: PRLD) share price represents “a particularly attractive buying opportunity,” and the stock has catalysts in the back half of the year, according to BofA Securities.